Italian Angelini family deploys $4.1B into U.S. biotech sector
Italy's $10 billion Angelini family has committed $4.1 billion in capital to U.S. biotech investments, marking one of the largest family office allocations to the sector this year.
Italy's $10 billion Angelini family has committed $4.1 billion in capital to U.S. biotech investments, marking one of the largest family office allocations to the sector this year.
Campbell Soup Company announced a dividend cut and a $500 million capital allocation plan amid pressure to strengthen its balance sheet and modernize operations.
Institutional reallocation in healthcare M&A is accelerating through direct family office buy-and-build platforms targeting lower middle market assets, displacing traditional PE sponsors.
All Aboard Capital announced a strategic pivot to focus the next fund on institutional investor sourcing and co-investment structures, moving away from syndicated venture positioning.
Asian family offices are increasing allocations to hedge funds and deep-value AI-related positions, signaling a shift toward liquid protection and relative value strategies.
Institutional investors are reconsidering utilities exposure as AI-driven power demand reshapes grid infrastructure economics and energy market fundamentals.
Multiple SPAC units including K2 Capital, Launch Two Acquisition, Soulpower Acquisition, and Crown Reserve are trading near $10.25-$10.45 as the sector awaits merger announcements.